Preview

General Reanimatology

Advanced search

Optimizing the Intensive Care Treatment of Delirium in Patients with 1,4-butanediol Intoxication

https://doi.org/10.15360/1813-9779-2020-3-85-93

Abstract

The aim of the study is to explore the best intensive care strategies for acute 1,4-butanediol poisoning complicated by post-intoxication delirium.

Materials and methods. The data of the laboratory testing and treatment of 40 men with acute severe poisoning with 1,4-butanediol, complicated by post-intoxication delirium were analyzed. Twenty patients received succinate-containing drug, others were treated with conventional methods. The control group included 18 healthy male patients aged 25 to 40 years. Clinical course of delirium, parameters of glutathione system and lipid peroxidation in patients' red blood cells, oxygen transport function (by indirect calorimetry), gammahydroxybutyric acid level in the biological fluids by gas chromatography/mass spectrometry were evaluated during the study.

Results. An increases in levels of reduced glutathione by 50.3% by day 7 (from 3.68±0.57 to 5.53±0.35 pmol/g), hemoglobin (Hb), antioxidant enzymes and glutathione reduction enzymes were found; glucose-6-phosphate dehydrogenase increased by 17,1% (from 3.68±0.26 to 4.31±0.41 pmol/g Hb) and glutathione reductase increased by 15% (from 174.1±16.3 to 200.2±4.11 pmol/min/g Hb). At the same time, the MDA lipid peroxidation system activation was decreased by 41.9% (from 7.78±1.06 to 4.52±0.28 nmol/g Hb).

Conclusion. The obtained data proved high efficacy of a succinate-containing drug in slowing down the progression of post-intoxication delirium through increasing the level of the main cellular antioxidant, the reduced glutathione.

About the Authors

A. G. Sinenchenko
Dzhanelidze Saint Petersburg Research Institute of Emergency Care
Russian Federation

Andrey G. Sinenchenko

3, Budapeshtskaya St., Saint Petersburg 192242



A. N. Lodyagin
Dzhanelidze Saint Petersburg Research Institute of Emergency Care
Russian Federation

Alexey N. Lodyagin

3, Budapeshtskaya St., Saint Petersburg 192242



B. V. Butotsyrenov
Dzhanelidze Saint Petersburg Research Institute of Emergency Care
Russian Federation

Bair V. Butotsyrenov

3, Budapeshtskaya St., Saint Petersburg 192242



References

1. SmirnovE.S. Delirium. The evolution of views. Rossijskij psikhiatric-heskij zhurnal. 2015; 5: 64-72 [In Russ.].

2. Likhvantsev V V Nonspecific delirium in the intensive care and resuscitation department. Anestesiol. i reanimatol. 2015; 60 (2): 55-59 [In Russ.].

3. LinevD. V, YaroshetskyA. I., Protsenko D. N., Gelfand B. R. The efficacy and safety of dexmedetomidine, haloperidol, and diazepam in the treatment of delirium: a comparative study. Anestesiol. i reanimatol. 2017; 62 (6): 442-448 [In Russ.]. DOI: 10.18821/0201-7563-2017-62-6-442-448

4. Sorensen H.J., Holst C., Knop J., Mortensen E.L., Tolstrup J.S., Becker U. Alcohol and delirium tremens: effects of average number of drinks per day and beverage type. Acta Psychiatr Scand. 2019; 139 (6): 518-525. DOI: 10.1111/acps.13006. PIMD: 30697683.

5. Campbell N.L. Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit. J Am Geriatr Soc. 2019; 67 (4): 695-702. DOI: 10.1111/jgs.15751. PMID: 30664239.

6. Grover S, Ghosh A. Delirium Tremens: Assessment and Management. J Clin Exp Hepatol. 2018; 8 (4): 460-470. DOI: 10.1016/j.jceh.2018.04.012. PMID: 30564004

7. Kireev S.S., Badakva T.L., Chukanova O.A. Delirium in the postoperative period (literature review). Vestnik novyh meditsinskih tekhno-logij. E-edition. 2019; 2: 44-60 [In Russ.].

8. Rubinchik V.E., Kasherininov I.Yu., Bautin A.E., Mazurok VA. Therapy of delirious syndrome in patients with a cardiac surgical profile in the early postoperative period. Vestnik intensivnoj terapii imeni A.I.Saltanova. 2019; 3: 77-83 [In Russ.]. DOI: 10.21320/1818-474X-2019-3-77-83

9. Sivolap Yu.P. Alcohol abuse and pharmacotherapy of alcoholism. Nevrologiya, nejropsikhiatriya, psikhosomatika. 2014 (3): 4-9 [In Russ.]. DOI: 10.14412/2074-2711-2014-3-4-9

10. Pleshakov A.A., Cherkudinov D.A. On the narcotic properties of sodium oxybutyrate and its non-medical use. Prikladnaya toksikologiya. 2012; 1 (7): 36-40 [In Russ.].

11. Golovko A.I., Leonteva L.V., Barinov V.A., Basharin VA., Bonitenko E.Yu., Golovko S.I., IvanovM.B. Identifying «rape drugs» in the biological environments of rape victims. Biomeditsinskij zhurnal. 2013; 14: 706-724 [In Russ.].

12. Zaikina O.L., LodyaginA.N., ShilovV.V. Gamma hydroxybutyrate and fentanyl derivatives: chemical-toxicological confirmation of poisoning. Sudebnaya meditsina.2016; 2 (2): 112-113 [In Russ.].

13. Stomberg M.W., Knudsen K., StombergH., Skarsater I. Symptoms and signs in interpreting gamma-hydroxybutyrate (GHB)intoxication — an explorative study. Scand J Trauma Resusc Emerg Med. 2014; (23): 22-27. DOI: 10.1186/1757-7241-22-27. PMID: 24758357

14. BusarddF.P.,JonesA.W. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol. 2015; 13 (1): 47-70. DOI: 10.2174/1570159X13666141210215423. PMID: 26074743

15. Corstens D. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB. J Forensic Leg Med. 2018; (54): 74-75. DOI: 10.1016/j.jflm.2017.12.008. PMID: 29328965

16. Beck R., Matanovic S.M., Zibar L. Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat. Arh Hig Rada Toksikol. 2019; 70 (2): 149-150. DOI: 10.2478/aiht-2019-70-3295. PMID: 31246568.

17. ByardR.W., CoxM., Stockham P. Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances. J Forensic Sci. 2016; 61 (6): 1546-1548. DOI: 10.1111/1556-4029.13212. PMID: 27723094

18. BerezkinA.S., GovorinN.VThe prognostic value of some indicators of lipid peroxidation and neuroimmune markers in patients with alcoholic delirium. Rossijskij psikhiatricheskij zhurnal. 2014; 6: 56-60 [In Russ.].

19. SakharovA.V., GolyginaS.E., Karavaeva T.M., MaksimenyaM.V. Indicators of peroxidation, antioxidant protection and neuromarkers for alcohol withdrawal syndrome (uncomplicated and complicated by delirium). Narkologiya. 2019; 6 (18): 66-72 [In Russ.]. DOI: 10.25557/1682-8313.2019.06.66-72

20. Байбурина Г.А., Нургалеева Е.А., Башкатов С.А. The interdependence of indicators of pro- and antioxidant systems of the brain and blood after ischemic damage in rats with different resistance to hypoxia. Meditsinskij vestnikBashkortostana.2015; 10 (58): 72-75 [In Russ.].

21. Livanov G.A., LodyaginA.N., BatotsyrenovB.V., LoladzeA.T., Baranov D.V.,NezhentsevaI.V. Optimization of Intensive Care of Patients with Delirium Tremens. General Reanimatology=Obshchaya Reanimato-logiya 2015; 11 (5): 25-33 [In Russ.]. DOI: 10.15360/1813-9779-2015-5-25-33


Review

For citations:


Sinenchenko A.G., Lodyagin A.N., Butotsyrenov B.V. Optimizing the Intensive Care Treatment of Delirium in Patients with 1,4-butanediol Intoxication. General Reanimatology. 2020;16(3):85-93. https://doi.org/10.15360/1813-9779-2020-3-85-93

Views: 906


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1813-9779 (Print)
ISSN 2411-7110 (Online)